2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

Journal: Nature Communications

Published: 2020-05-19

DOI: 10.1038/s41467-020-16126-7

Affiliations: 12

Authors: 25

Go to article
Institutions Share
CRUK Beatson Institute for Cancer Research, United Kingdom (UK) 0.46
Institute of Cancer Sciences (ICS), University of Glasgow, United Kingdom (UK) 0.22
Centre for Molecular Nanometrology, University of Strathclyde, United Kingdom (UK) 0.06
Department of Pure and Applied Chemistry, University of Strathclyde, United Kingdom (UK) 0.06
VIB-KU CCB Laboratory of Cellular Metabolism and Metabolic Regulation, Belgium 0.03
Laboratory of Cellular Metabolism and Metabolic Regulation (VRC), KU Leuven, Belgium 0.03
Leuven Cancer Institute (LKI), UZ Leuven, Belgium 0.03
Host-Graft-Tumor Interaction, Cell and Gene Engineering, France 0.03
Université Bourgogne Franche-Comté (UBFC), France 0.03
Dispositif Inter Régional d'Imagerie Cellulaire (DimaCell), France 0.03
Northern Institute for Cancer Research (NICR), Newcastle University, United Kingdom (UK) 0.02
School of Medical Education, Newcastle University, United Kingdom (UK) 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER